Language

Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.

Select Language
Hours of Operation
Monday through Friday 8:30 a.m. to 5:00 p.m.
Contact Us
Fax: 571.222.2202

Location Gallery

Location Tour

Publications

Safety and Antitumor Activity Study Evaluating Loncastuximab Tesirine and Rituximab Versus Immunochemotherapy in Diffuse Large B-Cell Lymphoma

December 6, 2020

NHL Patients and Nurses in the US Prefer Subcutaneous Rituximab Injection Versus Intravenous Rituximab Infusion: A Real-World Study

December 5, 2020

Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.

February 15, 2016

Pancreatitis in patients treated with Brentuximab Vedotin: A previously unrecognized serious adverse

May 1, 2014

Physicians